Re-live UEG Week

UEG Week edition 2026

UEG Week 2026 UEG Week 2025 UEG Week 2024 UEG Week 2023

until 09:30 · Room A1 PGT 6 on Gutflix

Acute pancreatitis: Are we still innocent bystanders?

until 09:30 · Room Dali PGT 5 on Gutflix

AI integration in my clinical practice today

until 09:30 · Room F1 PGT 7 on Gutflix

Quality in endoscopic practice

until 09:30 · Room Miro PGT 6 on Gutflix

Advanced colorectal cancer: Previously deadly, now chronic disease

until 09:30 · Room UEG Forum PGT 6 on Gutflix

Advanced chronic liver disease: When the liver gets stiff, the complications get going

more in parallel Show fewer

until 09:30 · Room A1 3 on Gutflix

Expanding the boundaries of transplant oncology

until 09:30 · Room A2 3 on Gutflix

Anastomotic headaches: What the gastroenterologist needs to know

until 09:30 · Room B1 6 on Gutflix

IBD diagnostics: In search of optimal implementation

until 09:30 · Room B2 5 on Gutflix

Pancreatic cyst: Beyond the incidental findings

until 09:30 · Room B3 4 on Gutflix

Public health aspects related to GI and steatotic liver disease (SLD)

until 09:30 · Room D1 6 on Gutflix

Clinical advances in Helicobacter pylori management

until 09:30 · Room D3 5 on Gutflix

New directions in the management and therapy of patients with hepatocellular carcinoma

until 09:30 · Room D4 6 on Gutflix

From modern diagnostics to treatments in coeliac disease

until 09:30 · Room Dali 3 on Gutflix

Therapy update: Acid-related disorders

until 09:30 · Room F1 5 on Gutflix

Mistakes in… Upper GI

until 09:30 · Room F2 6 on Gutflix

New horizons in digestive oncology

until 09:30 · Room Miro 3 on Gutflix

Interdisciplinary metabolic board for liver disease

until 09:30 · Room UEG Forum 4 on Gutflix

How to tackle PSC/IBD from a multidisciplinary perspective

more in parallel Show fewer

until 09:30 · Room A1 3 on Gutflix

Navigating between fake and truth in GI testing

until 09:30 · Room A2 3 on Gutflix

Hereditary polyposis syndromes: Making the hard choice

until 09:30 · Room B1 4 on Gutflix

Cross-cutting: Diagnostic - invasive or not invasive

until 09:30 · Room B2 6 on Gutflix

Endoscopy: Taming the biliary tree

until 09:30 · Room B3 6 on Gutflix

Hot topics in European Gastroenterology

until 09:30 · Room D1 6 on Gutflix

Beyond prescriptions: Improving IBD outcomes with non-pharmaceutical approaches

until 09:30 · Room D3 6 on Gutflix

The gut talks back

until 09:30 · Room D4 6 on Gutflix

Translational advances in upper gastrointestinal tract malignancies

until 09:30 · Room Dali 3 on Gutflix

Therapy update: Faecal incontinence

until 09:30 · Room F1 1 on Gutflix

ESGE live endoscopy I

until 09:30 · Room F2 6 on Gutflix

Lower GI disorders: A multidisciplinary approach

until 09:30 · Room Miro 3 on Gutflix

What’s new in… Locally advanced pancreatic cancer

until 09:30 · Room UEG Forum 5 on Gutflix

Looking into the future: Novel therapeutics in IBD (Part 1)

more in parallel Show fewer

until 10:30 · Room D1 4 on Gutflix

ESGENA: Opening Session

until 10:30 · Room UEG Forum PGT 7 on Gutflix

PGT Opening: How to make and not miss the diagnosis - Coeliac disease across the spectrum

until 11:30 · Room A1 PGT 9 on Gutflix

Eating disorders and unexplained weight loss

until 11:00 · Room B2 1 on Gutflix

Navigating the Treatment Journey with Subcutaneous Infliximab across Clinical Scenarios (Celltrion)

until 11:30 · Room D1 5 on Gutflix

Abstract II: Patient care and endoscopic techniques

until 11:30 · Room D3 4 on Gutflix

Colorectal cancer screening: New project – new data

until 11:30 · Room Dali PGT 6 on Gutflix

The pharyngoesophageal junction: A bottleneck in swallowing

until 11:30 · Room F1 PGT 9 on Gutflix

Bleeding less, clotting more: Unravelling coagulation disorders in liver disease

until 11:30 · Room Miro PGT 6 on Gutflix

Strategies in proctology: From diagnosis to multidisciplinary management

until 11:30 · Room UEG Forum PGT 8 on Gutflix

Thiopurines in IBD: Should I stay or should I go

more in parallel Show fewer

until 11:00 · Room A1 6 on Gutflix

Molecular trajectories of disease and drug responses in IBD

until 11:00 · Room A2 3 on Gutflix

What’s new in… Rome V?

until 11:00 · Room B1 3 on Gutflix

Translating metabolic insights into clinical practice: Key lessons for gastroenterologists

until 11:00 · Room B2 2 on Gutflix

Organ preservation in colorectal cancer dos and don’ts

until 11:00 · Room B3 6 on Gutflix

Anti-secretory therapy: Evolving standards and future horizons

until 11:00 · Room D1 5 on Gutflix

Lights, camera, lumen! High-impact endoscopy video cases

until 11:00 · Room D3 5 on Gutflix

Hot topics in clinical GI research

until 11:00 · Room D4 3 on Gutflix

Advances in oncology

until 11:00 · Room Dali 4 on Gutflix

Future treatment for resectable pancreatic cancer: Cut, treat or personalise?

until 11:00 · Room F1 3 on Gutflix

How to manage cirrhosis in 2026

until 11:00 · Room F2 6 on Gutflix

Steatotic liver disease: From screening and stigma to therapy

until 11:00 · Room Miro 3 on Gutflix

Complex enteropathies: From mechanisms to management

until 11:00 · Room UEG Forum 6 on Gutflix

Late-Breaking: IBD Trials

more in parallel Show fewer

until 11:00 · Room A1 3 on Gutflix

Let’s talk about bile ducts: From stones to cholestasis

until 11:00 · Room A2 3 on Gutflix

Black box problems in proctology

until 11:00 · Room B1 6 on Gutflix

Late-Breaking in IBD: From translational discoveries to treatment

until 11:00 · Room B2 3 on Gutflix

Upper GI endoscopy: Screen wisely

until 11:00 · Room B3 6 on Gutflix

One patient, multiple futures: Predicting outcomes in IBD

until 11:00 · Room D1 6 on Gutflix

Looking at the small details: Lessons from sub-studies of clinical trials in IBD

until 11:00 · Room D3 3 on Gutflix

Short bowel syndrome: Are we making progress?

until 11:00 · Room D4 4 on Gutflix

Nutrition, metabolism and the therapeutics of obesity

until 11:00 · Room Dali 3 on Gutflix

From guidelines to clinical practice: Digestive guidelines unplugged – what’s new, what’s next?

until 11:00 · Room F1 1 on Gutflix

ESGE live endoscopy II

until 11:00 · Room F2 5 on Gutflix

Achalasia: Beyond the bird's beak - Tailoring therapy to the patient

until 11:00 · Room Miro 3 on Gutflix

Rising stars from Europe and Japan

until 11:00 · Room UEG Forum 3 on Gutflix

Advances in hepatology

more in parallel Show fewer

until 12:30 · Room A1 PGT 6 on Gutflix

Scope it out: Endoscopic mastery in upper GI neoplasia

until 12:30 · Room D1 6 on Gutflix

New trends and developments in hygiene and infection control 

until 12:30 · Room D3 4 on Gutflix

New trends and developments in endoscopic techniques

until 12:30 · Room Dali PGT 4 on Gutflix

Pancreatic and small bowel neuroendocrine tumours

until 12:30 · Room F1 PGT 6 on Gutflix

H. pylori and precancerous conditions

until 12:30 · Room Miro PGT 6 on Gutflix

What’s new in diverticular disease of the colon

until 12:30 · Room UEG Forum PGT 9 on Gutflix

Monitoring of disease activity in IBD

more in parallel Show fewer

until 12:30 · Room A1 3 on Gutflix

IBD nutrition matters

until 12:30 · Room A2 6 on Gutflix

Long-term outcomes of interventional trials in IBD

until 12:30 · Room B1 3 on Gutflix

Metabolic aspects of immunomodulatory IBD therapy

until 12:30 · Room B2 3 on Gutflix

AI in upper GI endoscopy: Where are we? Where are we going?

until 12:30 · Room B3 4 on Gutflix

From molecules to microbiota in the upper GI tract

until 12:30 · Room D1 6 on Gutflix

Interventional endoscopy: What's new and cool!

until 12:30 · Room D3 6 on Gutflix

Insights into IBS

until 12:30 · Room D4 3 on Gutflix

Acute pancreatitis: From prevention to treatment

until 12:30 · Room Dali 2 on Gutflix

Disease primer: The role of the microbiome in pancreatitis and MASLD

until 12:30 · Room F1 3 on Gutflix

Crash course: Emergencies in lower GI

until 12:30 · Room F2 6 on Gutflix

Liver cirrhosis: A cirrhotic conundrum - Diagnosis and evaluation

until 12:30 · Room Miro 3 on Gutflix

Therapy update: Anti-obesity

until 12:30 · Room UEG Forum 3 on Gutflix

Preventing colorectal cancer using new European guidelines

more in parallel Show fewer

until 12:30 · Room A1 6 on Gutflix

Pancreatic cyst: From molecular insights to clinical care

until 12:30 · Room A2 3 on Gutflix

Gastro-oesophageal reflux: How to keep the acid down?

until 12:30 · Room B1 3 on Gutflix

Alleviating symptom burden in HPB diseases

until 12:30 · Room B2 3 on Gutflix

The future of immune-mediated metabolic diseases

until 12:30 · Room B3 6 on Gutflix

Looking into the future: Novel therapeutics in IBD (Part 2)

until 12:30 · Room D1 4 on Gutflix

FMT: Changing the rules

until 12:30 · Room D3 3 on Gutflix

How to study small bowel function in 2026? From the past to the future

until 12:30 · Room D4 5 on Gutflix

Evolving molecular paradigms in gastric cancer

until 12:30 · Room Dali 3 on Gutflix

What’s new in… Hepatitis and liver failure

until 12:30 · Room F1 1 on Gutflix

ESGE live endoscopy III

until 12:30 · Room F2 4 on Gutflix

H. pylori: At the nexus of molecular mechanisms and clinical care

until 12:30 · Room Miro 4 on Gutflix

Best of DDW

until 12:30 · Room UEG Forum 4 on Gutflix

A 360° multidisciplinary approach to obesity and metabolic health

more in parallel Show fewer

until 13:00 · Room A2 1 on Gutflix

MASH with Liver Fibrosis: From Growing Burden to Targeted Treatment (Madrigal Pharmaceutical)

until 13:00 · Room B1 1 on Gutflix

Can We Change the Course of EoE? Detecting, Preventing, and Targeting Remodeling in the Right Patient, at the Right Time (Sanofi Regeneron)

until 13:00 · Room D1 3 on Gutflix

AI in endoscopy: Friend or foe

until 13:00 · Room D3 3 on Gutflix

Patient care: Requirements for special patient groups

until 13:00 · Room D4 1 on Gutflix

After the first biologic failure, the next choice matters: Building confidence beyond conventional targets through comprehensive disease control with mirikizumab in UC (Eli Lilly and Company)

more in parallel Show fewer

until 14:00 · Room A1 1 on Gutflix

Autoimmunity in HPB

until 14:00 · Room B1 1 on Gutflix

Treating early colonic neoplasm

until 14:00 · Room B2 1 on Gutflix

After the first biologic failure, the next choice matters: Building confidence beyond conventional targets through deep remission with mirikizumab in CD (Eli Lilly and Company)

until 14:00 · Room D1 1 on Gutflix

Building on the Evidence for S1P Receptor Modulation in Ulcerative Colitis (Pfizer)

until 14:00 · Room D4 1 on Gutflix

Emergencies in upper GI

more in parallel Show fewer

until 14:00 · Room A1 1 on Gutflix

Management of cholestasis

until 14:00 · Room B1 1 on Gutflix

Surviving upper GI adverse events

until 14:00 · Room D3 1 on Gutflix

PSC-IBD crosstalk: From mechanisms to meaningful clinical practice (Dr. Falk Pharma)

until 14:00 · Room D4 1 on Gutflix

IBS: Young and old

until 14:00 · Room F1 1 on Gutflix

The EoE clinical recipe: ingredients from cause to care (AstraZeneca)

more in parallel Show fewer

until 15:00 · Room UEG Forum 9 on Gutflix

Opening plenary

until 15:00 · Room A1 PGT 5 on Gutflix

The acute abdomen: The good, bad and the ugly

until 15:00 · Room D1 5 on Gutflix

Innovative approaches in liver disease management – in cooperation with EASL nurses and AHP taskforce

until 15:00 · Room D3 5 on Gutflix

Abstract I: Management and education

until 15:00 · Room Dali PGT 6 on Gutflix

Avoid inflammation and intoxication: Management of autoimmune and alcohol-related liver disease

until 15:00 · Room F1 PGT 5 on Gutflix

Precision in practice: The future of drug optimisation in IBD

until 15:00 · Room Miro PGT 6 on Gutflix

Beyond calories: Managing complications and refeeding syndrome in clinical nutrition support

until 15:00 · Room UEG Forum PGT 6 on Gutflix

Are you stuck in the biliary cannulation nightmare: Wake up, here comes the sun

more in parallel Show fewer

until 15:00 · Room D1 4 on Gutflix

Green endoscopy and hygiene

until 15:00 · Room D3 4 on Gutflix

Advanced endoscopic techniques

until 15:30 · Room A1 6 on Gutflix

Lessons from large IBD real-world cohorts

until 15:30 · Room A2 6 on Gutflix

Late-Breaking: Advances in liver and pancreatic disease

until 15:30 · Room B1 3 on Gutflix

Gut microbiome in non-communicable disorders

until 15:30 · Room B2 3 on Gutflix

What’s new in… Screening in digestive cancer

until 15:30 · Room B3 3 on Gutflix

Never waste a good disaster

until 15:30 · Room D1 6 on Gutflix

Fire in the oesophagus: Mastering eosinophilic oesophagitis

until 15:30 · Room D3 3 on Gutflix

Transitioning into adulthood in gastroenterology

until 15:30 · Room D4 3 on Gutflix

Frontiers in pancreatic research and therapy

until 15:30 · Room Dali 3 on Gutflix

Gastroparesis and functional dyspepsia

until 15:30 · Room F1 3 on Gutflix

Advancing endoscopic resections in the colon

until 15:30 · Room F2 5 on Gutflix

The basics of future oncology

until 15:30 · Room Miro 3 on Gutflix

Frailty, cachexia and sarcopenia in liver disease

until 15:30 · Room UEG Forum 3 on Gutflix

Disease primer: Unexpected cellular players in IBD

more in parallel Show fewer

until 15:30 · Room A1 6 on Gutflix

Beyond colonoscopy: Improvements to come!

until 15:30 · Room A2 6 on Gutflix

Immunologic pathways of disease and drug response in IBD

until 15:30 · Room B1 2 on Gutflix

H. pylori: Progress in care

until 15:30 · Room B2 3 on Gutflix

Hot topics from Pan-America

until 15:30 · Room B3 6 on Gutflix

Real-world observations in IBD: Things we don't see in clinical trials

until 15:30 · Room D1 5 on Gutflix

Lower GI masterclass: Let's get educated!

until 15:30 · Room D3 3 on Gutflix

Non-achalasia dysphagia: From symptoms to solution

until 15:30 · Room D4 6 on Gutflix

Decoding the upper GI tract using biomarkers

until 15:30 · Room Dali 5 on Gutflix

Chronic pancreatitis

until 15:30 · Room F1 3 on Gutflix

Therapy update: Advanced therapy of gastro-oesophageal cancer

until 15:30 · Room F2 5 on Gutflix

Late-Breaking: Innovations from diagnosis to treatment

until 15:30 · Room Miro 3 on Gutflix

From guidelines to clinical practice: Pancreas in focus – new rules, bold moves

until 15:30 · Room UEG Forum 3 on Gutflix

What’s new in… Managing stricturing Crohn’s disease

more in parallel Show fewer

until 17:00 · Room A1 PGT 7 on Gutflix

Autoimmune pancreatitis: Come, see, conquer

until 17:00 · Room D1 2 on Gutflix

IBD-nurses: All around the gut – in cooperation with N-ECCO

until 17:00 · Room D3 4 on Gutflix

Education of patients and staff

until 17:00 · Room Dali PGT 6 on Gutflix

Cutting through the layers: Advances in diagnosis and treatment of oesophageal squamous cell carcinoma

until 17:00 · Room F1 PGT 7 on Gutflix

Decision-making in acute liver failure: From expectant management to emergency transplant

until 17:00 · Room Miro PGT 13 on Gutflix

Chronic constipation: How to diagnose and treat this frequent condition in clinical practice

until 17:00 · Room UEG Forum PGT 5 on Gutflix

Dilemmas in ulcerative colitis: Back to the basics or fast forward

more in parallel Show fewer

until 16:30 · Room A1 6 on Gutflix

Endoscopic resection: Cut, cure, prevent

until 16:30 · Room A2 2 on Gutflix

Quality indicators for pancreatic adenocarcinoma

until 16:30 · Room B1 3 on Gutflix

Cross-cutting: Diet and cancer

until 16:30 · Room B2 3 on Gutflix

Advancing imaging in HPB disease

until 16:30 · Room B3 6 on Gutflix

Abstract session: Hot topics in IBD

until 16:30 · Room D1 5 on Gutflix

New insights into IBD mechanisms

until 16:30 · Room D3 6 on Gutflix

Functional upper GI disorders: From epidemiology to therapies

until 16:30 · Room D4 3 on Gutflix

Cellular perspectives of immune control

until 16:30 · Room Dali 3 on Gutflix

After the surgeon: A glimpse behind the survival curves

until 16:30 · Room F1 3 on Gutflix

Personalised management in upper GI cancer

until 16:30 · Room F2 3 on Gutflix

ESGENA: Our most memorable cases

until 16:30 · Room Miro 3 on Gutflix

Mastering new antineoplastic treatments: What the gastroenterologist needs to know

until 16:30 · Room UEG Forum 3 on Gutflix

Navigating IBD therapies in 2026

more in parallel Show fewer

until 17:00 · Room A1 3 on Gutflix

Daily questions in the management of chronic pancreatitis

until 17:00 · Room A2 6 on Gutflix

Teaching an old dog new tricks: New implementations of current IBD drugs

until 17:00 · Room B1 3 on Gutflix

What can we learn from ‘failed’ IBD trials?

until 17:00 · Room B2 2 on Gutflix

Eosinophilic gastrointestinal diseases: From basic to clinical practice

until 17:00 · Room B3 6 on Gutflix

New horizons in cholestatic and biliary disease: Therapy, prognosis, and precision care

until 17:00 · Room D1 6 on Gutflix

Small intestine diseases: Inside the black box

until 17:00 · Room D3 3 on Gutflix

Ageing of the patient: Does metabolism matter?

until 17:00 · Room D4 4 on Gutflix

On bugs and food: New lessons in microbiomics and dietomics in IBD

until 17:00 · Room Dali 5 on Gutflix

Mistakes in… Hepatobiliary and pancreas

until 17:00 · Room F1 3 on Gutflix

The troublesome pouch

until 17:00 · Room F2 5 on Gutflix

Biliary clinical care: New frontiers in biliary endoscopy

until 17:00 · Room Miro 4 on Gutflix

Multidisciplinary tumour board session: Managing upper GI neoplasia

until 17:00 · Room UEG Forum 3 on Gutflix

Innovations in gut microbiota diagnostics and therapeutics

more in parallel Show fewer

until 18:00 · Room A1 3 on Gutflix

Controversies in lower GI: disorders of gut–brain interaction

until 18:00 · Room A2 3 on Gutflix

Optimising IBD care: When resources dry out

until 18:00 · Room B1 4 on Gutflix

Mistakes in… Lower GI

until 18:00 · Room B2 3 on Gutflix

Management of upper GI: Precancerous conditions and early neoplasia

until 18:00 · Room B3 3 on Gutflix

Extraintestinal manifestations in IBD

until 18:00 · Room D1 5 on Gutflix

Clinical aspects of viral hepatitis: Redefining viral hepatitis care - screening, fibrosis, reactivation, and cure

until 18:00 · Room D3 5 on Gutflix

Mapping molecular interactions in the upper gastrointestinal tract

until 18:00 · Room D4 5 on Gutflix

Pancreatic cancer: From bench to bedside

until 18:00 · Room Dali 3 on Gutflix

Bile acid metabolism

until 18:00 · Room F1 3 on Gutflix

Life after acute pancreatitis: Risks, surveillance and management

until 18:00 · Room F2 1 on Gutflix

ESGENA Quiz: Do you know it?

until 18:00 · Room Miro 3 on Gutflix

Therapy update: HPB oncology

until 18:00 · Room UEG Forum 6 on Gutflix

Late-Breaking: Advances in GI-endoscopy

more in parallel Show fewer

until 18:30 · Room B1 1 on Gutflix

The Liver as the Metabolic Hub: Connecting Obesity, MASLD/MASH, and GI Practice (Boehringer Ingelheim)

until 18:30 · Room B2 1 on Gutflix

The Inflammatory Intersection: Interactive Cases in Care for IBD and Obesity (Medscape Education Global)

until 18:30 · Room D3 1 on Gutflix

A new treatment paradigm – addressing fibro-inflammation in IBD (Agomab)

until 19:30 · Room B2 1 on Gutflix

The α‑Polymorph Advantage: Beyond Traditional Antibiotic Activity (ALFASIGMA)

until 19:30 · Room D1 1 on Gutflix

Guiding the care of hypertriglyceridemia-induced acute pancreatitis: Multidisciplinary care and the role of new therapies through apoC-III inhibition (Sobi (Swedish Orphan Biovitrum))